PDF herunterladen
Thromb Haemost 2018; 118(12): 2086-2097
DOI: 10.1055/s-0038-1675228
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation

Xiao-Min Zhao   *
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Yun Wang   *
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Yang Yu   *
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Hui Jiang
2   Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, United States
,
Anna Babinska
2   Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, United States
,
Xiu-Yu Chen
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Ke-Gui He
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Xiang-Dong Min
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Ji-Ju Han
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Chen-Xi Yang
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Kevin Deng
2   Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, United States
,
Jing Xue
3   Hebei Collaborative Innovation Center for Cardio-cerebrovascular Disease, Hebei Key Laboratory of Vascular Homeostasis, Shijiazhuang, China
,
Xiangjian Zhang
3   Hebei Collaborative Innovation Center for Cardio-cerebrovascular Disease, Hebei Key Laboratory of Vascular Homeostasis, Shijiazhuang, China
,
Guo-Hua Song
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Shu-Cun Qin
1   The Institute of Atherosclerosis, Taishan Medical University, Taian, China
,
Xian-Cheng Jiang
2   Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, New York, United States
4   Molecular and Cellular Cardiology Program, VA New York Harbor Healthcare System, Brooklyn, New York, United States
› Institutsangaben Funding This work was supported by China Natural Science Funds (31371190, 91539114, 81173061), Taishan Scholar Foundation of Shandong Province of China (ts201511057) and Natural Science Foundation of Shandong Province of China (ZR2014HQ007, ZR2017MH048), Veterans Affairs Merit award 000900–01 and National Institutes of Health grant R56HL121409.
Weitere Informationen

Publikationsverlauf

11. Januar 2018

12. September 2018

Publikationsdatum:
12. November 2018 (online)

    Lizenzen und Reprints

Abstract

It remains unclear whether plasma phospholipid transfer protein (PLTP) is involved in hyper-coagulation or hypo-coagulation. This study investigated the direct effect of PLTP on platelet aggregation and the underlying mechanism. Washed platelets from humans or mice and mouse platelet-rich plasma and human recombinant PLTP were isolated. PLTP is present in human platelets. We assessed adenosine diphosphate (ADP)-, collagen- and thrombin-induced platelet aggregation, phosphatidylserine externalization and photothrombosis-induced cerebral infarction in mice. PLTP over-expression increased platelet aggregation, while PLTP deficiency had the opposing reaction. Human recombinant PLTP increased both mouse and human platelet aggregation in a dose-dependent manner. Phosphatidylserine externalization provides a water/lipid surface for the interaction of coagulation factors, which accelerates thrombosis. Compared with wild-type controls, platelets from PLTP transgenic mice had significantly more phosphatidylserine on the exterior surface of the plasma membrane, whereas platelets from PLTP-deficient mice had significantly less phosphatidylserine on the surface, thus PLTP influences fibrinogen binding on the plasma membrane. Moreover, recombinant PLTP together with ADP significantly increased phosphatidylserine exposure on the plasma membrane of PLTP-deficient platelets, thereby increasing fibrinogen binding. PLTP over-expression significantly accelerated the incidence of photothrombosis-induced infarction in mice, whereas PLTP deficiency significantly reduced the frequency of infarction. We concluded that PLTP promotes phosphatidylserine externalization at the plasma membrane of platelets and accelerates ADP- or collagen-induced platelet aggregation. This effect plays an important role in the initiation of thrombin generation and platelet aggregation under sheer stress conditions. Thus, PLTP is involved in hyper-coagulation. Therefore, PLTP inhibition could be a novel approach for countering thrombosis.

Keywords

phospholipid transfer protein - platelet aggregation - phosphatidylserine externalization

Authors' Contributions

X.M.Z., Y.W. and Y.Y designed the study and performed most of the experiments, and they contributed equally to this work. H.J., A.B., X.Y.C., K.G.H., X.D.M., J.J.H., C.X.Y., J.X., X.Z. and G.H.S. performed some experiments. S.C.Q. and X.C.J. designed the study and wrote the manuscript.


* These authors contributed equally to this work.


Supplementary Material

 

  • References

  • 1 Kaser S, Sandhofer A, Föger B. , et al. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity. Diabetologia 2001; 44 (09) 1111-1117
    CrossrefPubMedGoogle Scholar
  • 2 Tzotzas T, Dumont L, Triantos A, Karamouzis M, Constantinidis T, Lagrost L. Early decreases in plasma lipid transfer proteins during weight reduction. Obesity (Silver Spring) 2006; 14 (06) 1038-1045
    CrossrefPubMedGoogle Scholar
  • 3 Borggreve SE, De Vries R, Dullaart RP. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest 2003; 33 (12) 1051-1069
    CrossrefPubMedGoogle Scholar
  • 4 van Tol A. Phospholipid transfer protein. Curr Opin Lipidol 2002; 13 (02) 135-139
    CrossrefPubMedGoogle Scholar
  • 5 Schlitt A, Bickel C, Thumma P. , et al. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 2003; 23 (10) 1857-1862
    CrossrefPubMedGoogle Scholar
  • 6 de Vries R, Dallinga-Thie GM, Smit AJ, Wolffenbuttel BH, van Tol A, Dullaart RP. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia 2006; 49 (02) 398-404
    CrossrefPubMedGoogle Scholar
  • 7 Dullaart RP, van Tol A, Dallinga-Thie GM. Phospholipid transfer protein, an emerging cardiometabolic risk marker: is it time to intervene?. Atherosclerosis 2013; 228 (01) 38-41
    CrossrefPubMedGoogle Scholar
  • 8 Colhoun HM, Scheek LM, Rubens MB. , et al. Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification. Diabetes 2001; 50 (03) 652-659
    CrossrefPubMedGoogle Scholar
  • 9 Schlitt A, Blankenberg S, Bickel C. , et al. PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene study. J Lipid Res 2009; 50 (04) 723-729
    CrossrefPubMedGoogle Scholar
  • 10 Vergeer M, Boekholdt SM, Sandhu MS. , et al. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Circulation 2010; 122 (05) 470-477
    CrossrefPubMedGoogle Scholar
  • 11 Robins SJ, Lyass A, Brocia RW, Massaro JM, Vasan RS. Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study. Atherosclerosis 2013; 228 (01) 230-236
    CrossrefPubMedGoogle Scholar
  • 12 Cavusoglu E, Marmur JD, Chhabra S. , et al. Elevated baseline plasma phospholipid protein (PLTP) levels are an independent predictor of long-term all-cause mortality in patients with diabetes mellitus and known or suspected coronary artery disease. Atherosclerosis 2015; 239 (02) 503-508
    CrossrefPubMedGoogle Scholar
  • 13 Yatsuya H, Tamakoshi K, Hattori H. , et al. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ J 2004; 68 (01) 11-16
    CrossrefPubMedGoogle Scholar
  • 14 Huuskonen J, Ekström M, Tahvanainen E. , et al. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between PLTP mass and phospholipid transfer activity. Atherosclerosis 2000; 151 (02) 451-461
    CrossrefPubMedGoogle Scholar
  • 15 Dullaart RP, De Vries R, Scheek L. , et al. Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations. Scand J Clin Lab Invest 2004; 64 (03) 205-215
    CrossrefPubMedGoogle Scholar
  • 16 Rühling K, Lang A, Richard F. , et al. Net mass transfer of plasma cholesteryl esters and lipid transfer proteins in normolipidemic patients with peripheral vascular disease. Metabolism 1999; 48 (11) 1361-1366
    CrossrefPubMedGoogle Scholar
  • 17 Schgoer W, Mueller T, Jauhiainen M. , et al. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis 2008; 196 (01) 219-226
    CrossrefPubMedGoogle Scholar
  • 18 Jiang XC, Qin S, Qiao C. , et al. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 2001; 7 (07) 847-852
    CrossrefPubMedGoogle Scholar
  • 19 van Haperen R, van Tol A, van Gent T. , et al. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J Biol Chem 2002; 277 (50) 48938-48943
    CrossrefPubMedGoogle Scholar
  • 20 Deckert V, Kretz B, Habbout A. , et al. Development of abdominal aortic aneurysm is decreased in mice with plasma phospholipid transfer protein deficiency. Am J Pathol 2013; 183 (03) 975-986
    CrossrefPubMedGoogle Scholar
  • 21 Masson D, Deckert V, Gautier T. , et al. Worsening of diet-induced atherosclerosis in a new model of transgenic rabbit expressing the human plasma phospholipid transfer protein. Arterioscler Thromb Vasc Biol 2011; 31 (04) 766-774
    CrossrefPubMedGoogle Scholar
  • 22 Manchekar M, Liu Y, Sun Z, Richardson PE, Dashti N. Phospholipid transfer protein plays a major role in the initiation of apolipoprotein B-containing lipoprotein assembly in mouse primary hepatocytes. J Biol Chem 2015; 290 (13) 8196-8205
    CrossrefPubMedGoogle Scholar
  • 23 Yazdanyar A, Jiang XC. Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice. Hepatology 2012; 56 (02) 576-584
    CrossrefPubMedGoogle Scholar
  • 24 Jiang XC, Tall AR, Qin S. , et al. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J Biol Chem 2002; 277 (35) 31850-31856
    CrossrefPubMedGoogle Scholar
  • 25 Yang XP, Yan D, Qiao C. , et al. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler Thromb Vasc Biol 2003; 23 (09) 1601-1607
    CrossrefPubMedGoogle Scholar
  • 26 Klein A, Deckert V, Schneider M. , et al. Alpha-tocopherol modulates phosphatidylserine externalization in erythrocytes: relevance in phospholipid transfer protein-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26 (09) 2160-2167
    CrossrefPubMedGoogle Scholar
  • 27 Desrumaux C, Deckert V, Lemaire-Ewing S. , et al. Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2452-2457
    CrossrefPubMedGoogle Scholar
  • 28 Oslakovic C, Krisinger MJ, Andersson A, Jauhiainen M, Ehnholm C, Dahlbäck B. Anionic phospholipids lose their procoagulant properties when incorporated into high density lipoproteins. J Biol Chem 2009; 284 (09) 5896-5904
    CrossrefPubMedGoogle Scholar
  • 29 Deguchi H, Wolfbauer G, Cheung MC. , et al. Inhibition of thrombin generation in human plasma by phospholipid transfer protein. Thromb J 2015; 13: 24
    CrossrefPubMedGoogle Scholar
  • 30 van Haperen R, van Tol A, Vermeulen P. , et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler Thromb Vasc Biol 2000; 20 (04) 1082-1088
    CrossrefPubMedGoogle Scholar
  • 31 Jiang XC, Bruce C, Mar J. , et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 1999; 103 (06) 907-914
    CrossrefPubMedGoogle Scholar
  • 32 Fukunaga K, Shimoyama T, Yamaji K, Yamane S, Sueoka A, Nosé Y. In vitro comparison study of CD63 and CD62P expression after contacting leukocyte filters. Artif Organs 1999; 23 (01) 108-113
    CrossrefPubMedGoogle Scholar
  • 33 Briedé JJ, Wielders SJ, Heemskerk JW, Baruch D, Hemker HC, Lindhout T. von Willebrand factor stimulates thrombin-induced exposure of procoagulant phospholipids on the surface of fibrin-adherent platelets. J Thromb Haemost 2003; 1 (03) 559-565
    CrossrefPubMedGoogle Scholar
  • 34 Das B, Yeger H, Tsuchida R. , et al. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res 2005; 65 (16) 7267-7275
    CrossrefPubMedGoogle Scholar
  • 35 Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM. Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 2000; 47 (05) 606-613
    CrossrefPubMedGoogle Scholar
  • 36 Whelihan MF, Zachary V, Orfeo T, Mann KG. Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation. Blood 2012; 120 (18) 3837-3845
    CrossrefPubMedGoogle Scholar
  • 37 Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996; 87 (04) 1409-1415
    PubMedGoogle Scholar
  • 38 Wilson MJ, Richter-Lowney K, Daleke DL. Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 1993; 32 (42) 11302-11310
    CrossrefPubMedGoogle Scholar
  • 39 Mallat Z, Hugel B, Ohan J, Lesèche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99 (03) 348-353
    CrossrefPubMedGoogle Scholar
  • 40 Suzuki J, Denning DP, Imanishi E, Horvitz HR, Nagata S. Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells. Science 2013; 341 (6144): 403-406
    CrossrefPubMedGoogle Scholar
  • 41 Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci U S A 1984; 81 (12) 3751-3755
    CrossrefPubMedGoogle Scholar
  • 42 Lhermusier T, Chap H, Payrastre B. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost 2011; 9 (10) 1883-1891
    CrossrefPubMedGoogle Scholar
  • 43 Bruce C, Beamer LJ, Tall AR. The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein. Curr Opin Struct Biol 1998; 8 (04) 426-434
    CrossrefPubMedGoogle Scholar
  • 44 Massey JB, Hickson D, She HS. , et al. Measurement and prediction of the rates of spontaneous transfer of phospholipids between plasma lipoproteins. Biochim Biophys Acta 1984; 794 (02) 274-280
    CrossrefPubMedGoogle Scholar
  • 45 Oram JF, Wolfbauer G, Tang C, Davidson WS, Albers JJ. An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. J Biol Chem 2008; 283 (17) 11541-11549
    CrossrefPubMedGoogle Scholar
  • 46 Yu Y, Guo S, Feng Y. , et al. Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability. Lipids 2014; 49 (02) 183-190
    CrossrefPubMedGoogle Scholar
  • 47 Van Reempts J, Borgers M. Histopathological characterization of photochemical damage in nervous tissue. Histol Histopathol 1994; 9 (01) 185-195
    PubMedGoogle Scholar
  • 48 Labat-gest V, Tomasi S. Photothrombotic ischemia: a minimally invasive and reproducible photochemical cortical lesion model for mouse stroke studies. J Vis Exp 2013; (76) 50370
    PubMedGoogle Scholar
  • 49 Levels JH, Pajkrt D, Schultz M. , et al. Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. Biochim Biophys Acta 2007; 1771 (12) 1429-1438
    PubMedGoogle Scholar
  • 50 Tan KC, Shiu SW, Wong Y, Tam S. Plasma phospholipid transfer protein activity and subclinical inflammation in type 2 diabetes mellitus. Atherosclerosis 2005; 178 (02) 365-370
    CrossrefPubMedGoogle Scholar
  • 51 Barlage S, Fröhlich D, Böttcher A. , et al. ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res 2001; 42 (02) 281-290
    PubMedGoogle Scholar
  • 52 Braig D, Nero TL, Koch HG. , et al. Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites. Nat Commun 2017; 8: 14188
    CrossrefPubMedGoogle Scholar